Trial intelligence / Profile preview

Optimizing morphine treatment in preterm neonates

NL-OMON24146Phase 2Active, not recruiting

Sponsor
Erasmus MC
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of morphine in pain (2 arms), sponsored by Erasmus MC. Primary endpoints: Safety, Pain response by NIP and PIPP and 3 more. Started Apr 2012; status: active, not recruiting.

02

Drugs

morphine
03

Conditions

pain

Beyond the preview

Go deeper on NL-OMON24146.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON24146.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call